TCM
BSX icon

Tributary Capital Management’s Boston Scientific BSX Stock Holding History

Tributary Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,100
Closed -$435K – 216
2020
Q4 		$435K Sell
12,100
-300
-2% -$10.8K 0.03% 191
2020
Q3 		$474K Sell
12,400
-350
-3% -$13.5K 0.04% 181
2020
Q2 		$448K Buy
12,750
+1,250
+11% +$45K 0.04% 182
2020
Q1 		$375K Sell
11,500
-200
-2% -$7.81K 0.04% 180
2019
Q4 		$529K Sell
11,700
-200
-2% -$8.37K 0.04% 180
2019
Q3 		$484K Sell
11,900
-600
-5% -$25.4K 0.04% 177
2019
Q2 		$537K Sell
12,500
-1,900
-13% -$73.1K 0.04% 176
2019
Q1 		$553K Sell
14,400
-3,000
-17% -$115K 0.04% 170
2018
Q4 		$615K Hold
17,400
– – 0.06% 163
2018
Q3 		$670K Hold
17,400
– – 0.05% 166
2018
Q2 		$569K Sell
17,400
-500
-3% -$15.1K 0.04% 175
2018
Q1 		$489K Sell
17,900
-2,400
-12% -$65.2K 0.04% 176
2017
Q4 		$503K Sell
20,300
-1,100
-5% -$30.3K 0.04% 183
2017
Q3 		$624K Sell
21,400
-1,700
-7% -$46.9K 0.05% 173
2017
Q2 		$640K Sell
23,100
-51,300
-69% -$1.36M 0.06% 173
2017
Q1 		$1.85M Sell
74,400
-37,000
-33% -$900K 0.18% 94
2016
Q4 		$2.41M Sell
111,400
-2,900
-3% -$63.3K 0.28% 82
2016
Q3 		$2.72M Sell
114,300
-2,900
-2% -$69.2K 0.35% 81
2016
Q2 		$2.74M Sell
117,200
-17,530
-13% -$379K 0.4% 82
2016
Q1 		$2.53M Hold
134,730
– – 0.4% 91
2015
Q4 		$2.48M Buy
134,730
+36,330
+37% +$651K 0.41% 88
2015
Q3 		$1.61M Buy
+98,400
New +$1.68M 0.27% 117

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Tributary Capital Management's BSX Position: Q1 2021 in Review

Tributary Capital Management sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 12,100 shares — an estimated $435K sold.

Tributary Capital Management first reported a position in BSX in Q3 2015 and held it in 22 quarters. The position peaked at $2.74M in Q2 2016. 832 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • Tributary Capital Management reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
  • Tributary Capital Management sold 12,100 Boston Scientific shares in Q1 2021, an estimated $435K.
  • Tributary Capital Management first reported a position in Boston Scientific in Q3 2015 and held it in 22 quarters.
  • Tributary Capital Management's Boston Scientific position peaked at $2.74M in Q2 2016.
  • 832 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Tributary Capital Management's 13F filing for Q1 2021, filed 20 Apr 2021.